Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Northeastern University, Boston, Massachusetts, USA.
Clin Infect Dis. 2022 Jan 29;74(2):237-245. doi: 10.1093/cid/ciab380.
Both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection and persistent infection have been reported, but sequence characteristics in these scenarios have not been described. We assessed published cases of SARS-CoV-2 reinfection and persistence, characterizing the hallmarks of reinfecting sequences and the rate of viral evolution in persistent infection.
A systematic review of PubMed was conducted to identify cases of SARS-CoV-2 reinfection and persistence with available sequences. Nucleotide and amino acid changes in the reinfecting sequence were compared with both the initial and contemporaneous community variants. Time-measured phylogenetic reconstruction was performed to compare intrahost viral evolution in persistent SARS-CoV-2 to community-driven evolution.
Twenty reinfection and 9 persistent infection cases were identified. Reports of reinfection cases spanned a broad distribution of ages, baseline health status, reinfection severity, and occurred as early as 1.5 months or >8 months after the initial infection. The reinfecting viral sequences had a median of 17.5 nucleotide changes with enrichment in the ORF8 and N genes. The number of changes did not differ by the severity of reinfection and reinfecting variants were similar to the contemporaneous sequences circulating in the community. Patients with persistent coronavirus disease 2019 (COVID-19) demonstrated more rapid accumulation of sequence changes than seen with community-driven evolution with continued evolution during convalescent plasma or monoclonal antibody treatment.
Reinfecting SARS-CoV-2 viral genomes largely mirror contemporaneous circulating sequences in that geographic region, while persistent COVID-19 has been largely described in immunosuppressed individuals and is associated with accelerated viral evolution.
已有严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)再感染和持续感染的报道,但这些情况下的序列特征尚未描述。我们评估了已发表的 SARS-CoV-2 再感染和持续感染病例,描述了再感染序列的特征以及持续感染中病毒进化的速率。
对 PubMed 进行了系统回顾,以确定具有可用序列的 SARS-CoV-2 再感染和持续感染病例。将再感染序列中的核苷酸和氨基酸变化与初始和同期社区变体进行比较。进行时间测量的系统发育重建,以比较持续 SARS-CoV-2 中的宿主内病毒进化与社区驱动的进化。
确定了 20 例再感染和 9 例持续感染病例。再感染病例报告的年龄、基线健康状况、再感染严重程度分布广泛,最早在初次感染后 1.5 个月或 >8 个月发生。再感染病毒序列的核苷酸中位数有 17.5 处变化,ORF8 和 N 基因富集。变化数量与再感染严重程度无关,再感染变体与同期在社区中流行的序列相似。持续性 COVID-19 患者的序列变化比社区驱动的进化更快,在恢复期血浆或单克隆抗体治疗期间持续进化。
再感染的 SARS-CoV-2 病毒基因组在很大程度上反映了该地区同期流行的序列,而持续性 COVID-19 主要发生在免疫功能低下的个体中,并与病毒加速进化有关。